Zerhouni has served as President and Vice Chairman of the Board of OPKO Health since May 2022; he was chairman and co-founder of ModeX Therapeutics from October 2020 until its acquisition by OPKO in May 2022. He previously served as President, Global Research & Development for Sanofi S.A. from 2011 to June 2018, as director of the National Institutes of Health from 2002 to 2008, and earlier as Chair of the Department of Radiology at the Johns Hopkins School of Medicine. A physician and world-renowned radiology researcher, he chairs Danaher's Science & Technology Committee.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.